Collectively, our findings suggest that the increased expression of TRIM26 hinders the development of cells by disrupting ETK, leading to the deactivation of AKT/mTOR signaling in ccRCC. The gene discussed is TRIM26; the disease is nonpapillary renal cell carcinoma.